Erectile dysfunction and sildenafil citrate and cardiologists

American Journal of Cardiology

Volumn 83, Issue 4, 1999, Pages 576-582

  Kloner, Robert A ^a   Jarow, Jonathan P ^b  

^a GOOD SAMARITAN HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NITRATE; PHENTOLAMINE; SILDENAFIL;

CARDIOVASCULAR RISK; DRUG EFFECT; DRUG EFFICACY; DYSPEPSIA; ERECTILE DYSFUNCTION; FUNCTIONAL ANATOMY; HEADACHE; HUMAN; MALE; NOSE CONGESTION; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EID: 0033557525     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00916-3     Document Type: Note

References (35)

1. NIH Consensus Development Panel on Impotence. NIH Consensus Conference: Impotence. JAMA 1993;270:83-90.
2. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
3. Licht MR. Sildenafil (Viagra) for treating male erectile dysfunction. Clevel Clin J Med 1998;65:301-304.
4. Benson GS, Boileau MA. The penis: Sexual function and dysfunction. In: Gillenwater JY, Grayhack JT, Howards SS, Duckett JW, eds. Adult and Pediatric Urology. Third Edition. St. Louis: Mosby, 1996:1951-1993.
5. Lue TF, Broderick G. Evaluation and nonsurgical management of erectile dysfunction and priapism. In: Walsh PC, ed. Campbell's Urology. 7th Edition. Philadelphia: WB Saunders, 1998:1181-1207.
6. McConnell JD, Wilson JD. Impotence. In: Fauci AS, Braundwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, eds. Harrison's Principles of Internal Medicine. 14th ed. 1998:286-289.
7. Azadzoi KM, Siroky MB, Goldstein I. Study of etiologic relationship of arterial atherosclerosis to corporal veno-occlusive dysfunction in the rabbit. J Urol 1996;155:1795-1800.
8. Virag R, Bouilly P, Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985;322:181-184.
9. Wei M, Macera CA, Davis DR, Hornung CA, Nankin HR, Blair SN. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol 1994;140:930-937.
10. Klein R, Klein BEK, Lee KE, Moss SE, Cruickshanks KJ. Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care 1996;19:135-141.
11. Greenstein A, Chen J, Miller H, Matzkin H, Villa Y, Braf Z. Does severity of ischemic coronary disease correlate with erectile function? Int J Impotence Res 1997;9:123-126.
12. Dhabuwala CB, Kumar A, Pierce JM. Myocardial infarction and its influence on male sexual function. Arch Sexual Behavior 1986;15:499-504.
13. Heaton JPW, Evans H, Adams MA, Smith K, Morales A. Coronary artery bypass graft surgery and its impact on erectile function: a preliminary retrospective study. Int J Impotence Res 1996;8:35-39.
14. Morley JE, Kaiser FE. Sexual function with advancing age. Geriatric Med 1989;73:1483-1495.
15. Padma-Nathan H, Hellstrom WJG, Kaiser FE, Labasky RF, Lue TF, Nolten WE, Norwood PC, Peterson CA, Shabsigh R, Tam PY, Place VA, Gesundheil N, for the Medicated Urethral System for Erection (MUSE) Study Group. Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med 1997;336:1-7.
16. Linet OI, Ogrinc FG. Efficacy and safety of intracavenosal alprostadil in men with erectile dysfunction. N Engl J Med 1996;334:873-877.
17. Boolell M, Gepi-Attee S, Gingell JC, Allen MJ. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urology 1996;78:257-261.
18. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA, for the Sildenafil Study Group. Oral sildenafil citrate in the treatment of erectile dysfunction. N Engl J Med 1998;338:1397-1404.
19. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-830.
20. Viagra (Sildenafil citrate). Full Prescribing Information. Monograph. Pfizer U.S. Pharmaceutical, April 1998.
21. Cimons M. FDA details death of 16 Viagra users. Los Angeles Times. p. A24, June 10, 1998.
22. Jeffrey NA, Langreth R. Viagra's lesson: new drugs, unknown risks. The Wall Street Journal, p. B1, June 10, 1998.
23. Sharpe R. FDA received adverse data about Viagra. The Wall Street Journal, p. B6, June 29, 1998.
24. Data from FDA website. August 24, 1998.
25. American Heart Association. 1998 Heart and Stroke-Statistical Update. Dallas, Texas: American Heart Association Monograph, 1997.
26. Kloner RA, Leor J, Poole WK, Perritt R. Population-based analysis of the effect of the Northridge earthquake on cardiac death in Los Angeles County, California. J Am Coll Cardiol 1997;30:1174-1180.
27. Muller JE, Mittleman MA, Maclure M, Sherwood JB, Tofler GH, for the Determinants of Myocardial Infarction Onset Study Investigators. Triggering myocardial infarction by sexual activity. Low absolute risk and prevention by regular physical exertion. JAMA 1996;275:1405-1409.
28. El-Sakka AI, Lue TF. Does a heart attack mean the end of sexual life? ACC Educational Highlights/Winter 1996;6-9.
29. Cheitlin MD, Hutter AM, Brindis RG, Ganz P, Gibbons RJ, Kaul S, Russell RO, Zusman RM. ACC/AHA summary statement on the use of Sildenafil (Viagra™) in patients at clinical risk from cardiovascular effects. August 10, 1998 (ACC website).
30. Becker AJ, Steif CG, Machtens S, Schultheiss D, Hartman U, Truss MC, Jonas U. Oral phentolamine as treatment for erectile dysfunction. J Urol 1998; 159:1214-1216.
31. Zorgniotti AW. Experience with buccal phentolamine mesylate for impotence. Int J Impotence Res 1994:6:37-41.
32. Drory Y, Shapira I, Fisman EZ, Pines A. Myocardial ischemia during sexual activity in patients with coronary artery disease. Am J Cardiol 1995;75:835-837.
33. Morales A, Gingell C, Collins M, Wicker PA, Osterloh IH. Clinical safety of oral Sildenafil citrate (Viagra™) in the treatment of erectile dysfunction. Int J Impot Res 1998;10:69-74.
34. FDA Website. November 1998.
35. Viagra (sidenafil citrate) revised package insert. November 1998.